Biopatent Law: Patent Strategies and Patent Management [electronic resource] /by Andreas Hübel, Thilo Schmelcher, Ulrich Storz.
by Hübel, Andreas [author.]; Schmelcher, Thilo [author.]; Storz, Ulrich [author.]; SpringerLink (Online service).
Material type: BookSeries: SpringerBriefs in Biotech Patents: Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg, 2012.Description: XII, 44p. 1 illus. in color. online resource.ISBN: 9783642248467.Subject(s): Life sciences | Pharmaceutical technology | Biotechnology | Biochemistry | Cytology | Microbiology | Commercial law | Life Sciences | Cell Biology | Pharmaceutical Sciences/Technology | Microbiology | Biochemistry, general | Biotechnology | Commercial LawDDC classification: 571.6 Online resources: Click here to access onlineItem type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
MAIN LIBRARY | QH573-671 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
QA75.5-76.95 Digital Libraries: For Cultural Heritage, Knowledge Dissemination, and Future Creation | TJ210.2-211.495 Structure from Motion using the Extended Kalman Filter | R856-857 Biomedical Signals and Sensors I | QH573-671 Biopatent Law: Patent Strategies and Patent Management | HF54.5-54.56 The Practice of Enterprise Modeling | TP155-156 Desalination Concentrate Management | QH324.2-324.25 Pattern Recognition in Bioinformatics |
Andreas Huebel: General Issues of Biotech Patents -- Thilo Schmelcher: Active and Passive Patent Strategies -- Ulrich Storz: Patent Lifetime Management, SPCs and Data Exclusivity.
Patents protecting biotechnological invention become ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
There are no comments for this item.